Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral reboundAfam A. Okoye, Jeffrey D. Lifson|Nature Medicine|2018Cited by 128
CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplificationAfam A. Okoye, Louis J. Picker|Journal of Clinical Investigation|2021Cited by 38
The ingenol-based protein kinase C agonist GSK445A is a potent inducer of HIV and SIV RNA transcriptionAfam A. Okoye, Nicolas Chomont|PLoS Pathogens|2022Cited by 22